Martis Capital announced that it has acquired a majority equity stake in Deerfield Group, a marketing, communications, media, and technology agency focused on healthcare and life sciences. Financial terms of the transaction were not disclosed.
Deerfield Group’s founders and members of its management team will retain significant ownership in the company.
Martis Capital is a private equity firm focused exclusively on the middle-market healthcare industry.
Deerfield Group is based in the Philadelphia area and serves pharmaceutical, biotechnology, health tech, and consumer health companies.
The company has increased revenue by more than 30% annually since 2017.
Martis Capital said the investment will provide Deerfield Group with additional resources to expand its capabilities, strengthen current offerings, and develop new technology solutions.
The investment is also expected to help Deerfield continue supporting healthcare and pharmaceutical clients across all stages of the lifecycle.
Deerfield Group provides services including insights and strategy, creative and digital, omnichannel marketing, media, public relations, data and analytics, sales enablement, and print management.
The company’s Agency of Brand model integrates these services to deliver marketing, media, communications, and digital solutions at scale.
Martis Capital said Deerfield has built a differentiated platform at the intersection of healthcare, integrated marketing, media, communications, and technology.
Deerfield said it is positioning itself as the Agency of Intelligence by combining human expertise with artificial intelligence to deliver more strategic and effective solutions for clients.
With Martis Capital’s support, Deerfield plans to deepen its capabilities, strengthen its team, advance analytics and AI-enabled solutions, and continue serving life sciences organizations ranging from early-stage biotechnology companies to large pharmaceutical companies.
Martis Capital is based in Washington, D.C., San Francisco, and Miami.
Since 2011, the firm has raised more than $2.2 billion from institutional clients to invest in middle-market North American healthcare companies.
KEY QUOTES:
“We are investing in Deerfield Group because it has built a differentiated platform at the intersection of healthcare, integrated marketing, media, communications and technology. The Deerfield team is a trusted partner to clients and has a strong reputation for strategy, responsiveness, execution, and results. We see meaningful opportunity to support Deerfield in delivering high-value growth for clients across the biotech and pharma ecosystem.”
Mario Moreno, Managing Partner at Martis Capital
“Deerfield is entering this next chapter from a position of strength as we serve as the Agency of Intelligence for clients—bringing together the power of our human intelligence (HI) and expertise with artificial intelligence (AI) to create more strategic, more effective solutions at the pace of client innovation. Our clients consistently value Deerfield as a trusted, highly responsive partner that delivers strategy, creative, media and communications with the agility, senior-level attention, and efficiency that other agencies often struggle to match. With Martis, our focus will remain on providing flexible, high-touch collaboration while deepening our capabilities, strengthening our bench, advancing our analytics and AI-enabled solutions, and ensuring we continue to be the partner of choice for life science organizations ranging from early stage biotech to large pharma.”
Frank Burrell, CEO of Deerfield Group
